| Identification | Back Directory | [Name]
Ethanediamide, N1-(4-chlorophenyl)-N2-[[5-(2-hydroxyethyl)-4-methyl-2-thiazolyl]-2-piperidinylmethyl]- | [CAS]
1375736-65-4 | [Synonyms]
NBD10007
NBD-10007
NBD 10007
Ethanediamide, N1-(4-chlorophenyl)-N2-[[5-(2-hydroxyethyl)-4-methyl-2-thiazolyl]-2-piperidinylmethyl]- | [Molecular Formula]
C20H25ClN4O3S | [MOL File]
1375736-65-4.mol | [Molecular Weight]
436.96 |
| Hazard Information | Back Directory | [Description]
NBD-10007 is a HIV-1 entry inhibitor. | [Uses]
NBD-10007 is a CD4 agonist. NBD-10007 has anti-HIV-1 viral activity[1]. | [References]
[1] Curreli F, et al. Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study. Antimicrob Agents Chemother. 2014 Sep;58(9):5478-91. DOI:10.1128/AAC.03339-14 |
|
|